182 related articles for article (PubMed ID: 8423079)
1. Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.
Peterson EM; Cheng X; Pal S; de la Maza LM
Infect Immun; 1993 Feb; 61(2):498-503. PubMed ID: 8423079
[TBL] [Abstract][Full Text] [Related]
2. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
Peterson EM; Cheng X; Motin VL; de la Maza LM
Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
[TBL] [Abstract][Full Text] [Related]
3. Expression of Fc gamma RIII on HeLa 229 cells: possible effect on in vitro neutralization of Chlamydia trachomatis.
Su H; Spangrude GJ; Caldwell HD
Infect Immun; 1991 Oct; 59(10):3811-4. PubMed ID: 1832664
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.
Qu Z; Cheng X; de la Maza LM; Peterson EM
Infect Immun; 1993 Apr; 61(4):1365-70. PubMed ID: 7681045
[TBL] [Abstract][Full Text] [Related]
5. Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies.
Brossay L; Villeneuve A; Paradis G; Coté L; Mourad W; Hébert J
Infect Immun; 1994 Feb; 62(2):341-7. PubMed ID: 7507888
[TBL] [Abstract][Full Text] [Related]
6. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity.
Peterson EM; Zhong GM; Carlson E; de la Maza LM
Infect Immun; 1988 Apr; 56(4):885-91. PubMed ID: 3346076
[TBL] [Abstract][Full Text] [Related]
7. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
Pal S; Bravo J; Peterson EM; de la Maza LM
Infect Immun; 2008 Dec; 76(12):5581-7. PubMed ID: 18809664
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
[TBL] [Abstract][Full Text] [Related]
9. Antigenic topology of chlamydial PorB protein and identification of targets for immune neutralization of infectivity.
Kawa DE; Stephens RS
J Immunol; 2002 May; 168(10):5184-91. PubMed ID: 11994474
[TBL] [Abstract][Full Text] [Related]
10. Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera.
Lampe MF; Wong KG; Kuehl LM; Stamm WE
Infect Immun; 1997 Jan; 65(1):317-9. PubMed ID: 8975931
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of Chlamydia trachomatis: kinetics and stoichiometry.
Peeling RW; Brunham RC
Infect Immun; 1991 Aug; 59(8):2624-30. PubMed ID: 1855982
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
Su H; Parnell M; Caldwell HD
Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae.
Peterson EM; de la Maza LM; Brade L; Brade H
Infect Immun; 1998 Aug; 66(8):3848-55. PubMed ID: 9673271
[TBL] [Abstract][Full Text] [Related]
15. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein.
Caldwell HD; Perry LJ
Infect Immun; 1982 Nov; 38(2):745-54. PubMed ID: 7141712
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody neutralization of unmanipulated Chlamydia trachomatis serovar A infection of human epithelioid cells (A-431).
Barsoum IS; Goodman TA; Hardin LK; Colley DG
Med Microbiol Immunol; 1989; 178(2):113-20. PubMed ID: 2733633
[TBL] [Abstract][Full Text] [Related]
18. Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies.
Peterson EM; Cheng X; Markoff BA; Fielder TJ; de la Maza LM
Infect Immun; 1991 Nov; 59(11):4147-53. PubMed ID: 1718870
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the humoral response elicited in mice by a chimeric peptide representing variable segments I and IV of the major outer membrane protein of Chlamydia trachomatis.
Qu Z; Cheng X; de la Maza LM; Peterson EM
Vaccine; 1994 May; 12(6):557-64. PubMed ID: 7518628
[TBL] [Abstract][Full Text] [Related]
20. Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis.
Motin VL; de la Maza LM; Peterson EM
Clin Diagn Lab Immunol; 1999 May; 6(3):356-63. PubMed ID: 10225836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
